Riskpilot← Back to searchSign inGet full accessCrosstrials AB
ABActiveOrg 5591530430Stora Långbro 1Raising of other animals · NACE 0148Est. 20181 employees
Revenue 2025
SEK 1,3M
-35% vs 2024
EBITDA margin
1.4%
+105% vs 2024
Equity ratio
41.1%
Financial strength
Net profit 2025
SEK 19K
+105% vs 2024
| Revenue | SEK 1,3M | -35% |
| EBITDA | SEK 18K | +105% |
| Net profit | SEK 19K | +105% |
| Total assets | SEK 284K | -35% |
| Equity | SEK 117K | +19% |
| Employees | 1 | — |
Legal name
Crosstrials AB
Org number
5591530430
Legal form
Aktiebolag
NACE code
0148 · Raising of other animals
Founded
19 mars 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget kommer bedriva uppfödning och utbildning av sociala tjänstehundar och därmed förenlig verksamhet. Företaget kommer bedriva uppfödning och utbildning av jakthundar, samt hålla kurser och föredrag inom ämnet hund och hundträning för hundägare, dels i egen regi, dels som inhyrd konsult i andra företags regi.
Address
Stora Långbro 1
Email
info@crosstrials.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 336 | 2 514 | 2 779 | 1 957 | 1 262 |
| Staff expenses | — | −306 | −302 | −317 | −4 |
| EBITDA | 56 | −38 | 353 | −397 | 18 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 56 | −38 | 353 | −397 | 18 |
| Net financials | — | −0 | 1 | 1 | 1 |
| Profit before tax | 56 | −38 | 354 | −397 | 19 |
| Tax | −12 | — | −65 | — | — |
| Net profit | 44 | −38 | 289 | −397 | 19 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 016 | 875 | 751 | 438 | 284 |
| Equity | 593 | 505 | 495 | 98 | 117 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 423 | 369 | 257 | 340 | 167 |
| Total debt | 423 | 369 | 257 | 340 | 167 |
EBITDA margin
1.4%
This company
15.8%
Market median
-91% vs market
20212025
Equity ratio
41.1%
This company
38.2%
Market median
+8% vs market
20212025
Return on equity
16.3%
This company
18.4%
Market median
+11% vs market
20212025
Net profit margin
1.5%
This company
8.1%
Market median
-81% vs market
20212025
Asset turnover
4.44×
This company
1.12×
Market median
+296% vs market
20212025
Debt / equity
1.43×
This company
0.62×
Market median
-131% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Crosstrials AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Roland Ragnar Londré | Deputy Board Member | 0 companies |
| Anna Londré | Board of Directors | 0 companies |